SCHEMBL22967418

SCHEMBL22967418

CC(C)(C)CC1(N2CCCC2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22967657 0.93 MEN1 (0.32) —
SCHEMBL22967931 0.93 MEN1 (0.35) —
SCHEMBL11989201 0.91 MEN1 (0.37) —
SCHEMBL18177230 0.91 KCNH2 (0.33) —
SCHEMBL15496992 0.80 LMNA (0.33) —
SCHEMBL12437271 0.76 LMNA (0.41) —
SCHEMBL26004583 0.74 — —
SCHEMBL12717845 0.74 SLC6A9 (0.32) —
SCHEMBL22967420 0.73 — —
SCHEMBL22967467 0.71 FTO (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210040089-A1 KRAS MUTANT PROTEIN INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. 2021-02-11 — — US disclosed
Send feedback